"Fibrinolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
| Descriptor ID |
D005343
|
| MeSH Number(s) |
D27.505.519.421.750 D27.505.954.411.320 D27.505.954.502.427
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolytic Agents".
This graph shows the total number of publications written about "Fibrinolytic Agents" by people in this website by year, and whether "Fibrinolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 2 | 5 |
| 2000 | 1 | 2 | 3 |
| 2001 | 6 | 2 | 8 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 3 | 5 |
| 2005 | 1 | 1 | 2 |
| 2006 | 3 | 1 | 4 |
| 2007 | 3 | 1 | 4 |
| 2008 | 6 | 0 | 6 |
| 2009 | 3 | 5 | 8 |
| 2010 | 2 | 1 | 3 |
| 2011 | 9 | 1 | 10 |
| 2013 | 8 | 2 | 10 |
| 2014 | 3 | 2 | 5 |
| 2015 | 3 | 2 | 5 |
| 2016 | 4 | 1 | 5 |
| 2017 | 2 | 1 | 3 |
| 2018 | 6 | 2 | 8 |
| 2019 | 5 | 4 | 9 |
| 2020 | 7 | 4 | 11 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 10 | 10 |
| 2023 | 1 | 6 | 7 |
| 2024 | 3 | 1 | 4 |
| 2025 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrinolytic Agents" by people in Profiles.
-
Assessing the impact of emergency medicine pharmacists on fibrinolytic door-to-needle times in acute ischemic stroke: A systematic review and meta-analysis (Pharmacist-assisted Stroke Treatments I (PhAST-1)). Am J Emerg Med. 2025 Dec; 98:57-64.
-
Emergency Physician Versus Telemedicine Neurologist Assessment for Thrombolytic Indication in the Treatment of Acute Ischemic Stroke (AIS). Acad Emerg Med. 2026 Jan; 33(1):e70096.
-
Comparison of combined intravenous and intra-arterial thrombolysis with intravenous thrombolysis alone in stroke patients undergoing mechanical thrombectomy: a propensity-matched analysis. J Neurointerv Surg. 2025 Jun 01; 17(e2):e261-e268.
-
Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin? Cardiol J. 2025; 32(3):321-327.
-
Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update. J Vasc Surg. 2025 Aug; 82(2):303-326.e11.
-
A Comparison of Postprocedural Hemoglobin in Catheter-Directed Thrombolysis versus Large-Bore Aspiration Thrombectomy for Acute Pulmonary Embolism. J Vasc Interv Radiol. 2025 01; 36(1):116-123.e1.
-
Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clin Cardiol. 2024 Oct; 47(10):e70026.
-
Histotripsy and Catheter-Directed Lytic: Efficacy in Highly Retracted Porcine Clots In Vitro. Ultrasound Med Biol. 2024 08; 50(8):1167-1177.
-
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 07; 106(1):145-153.
-
Apixaban for Prevention of Thromboembolism in Pediatric Heart?Disease. J Am Coll Cardiol. 2023 12 12; 82(24):2296-2309.